PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM

PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM was reported 19887 times

PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 32 0.0788
1 GEOTRICHUM INFECTION 16 0.0758
2 TRICHOSPORON INFECTION 28 0.0691
3 SPINAL MUSCULAR ATROPHY 17 0.0630
4 ACID BASE BALANCE ABNORMAL 13 0.0580
5 PYROGLUTAMIC ACIDOSIS 22 0.0554
6 CHOROIDITIS 20 0.0535
7 SCROTAL ABSCESS 19 0.0503
8 LINEAR IGA DISEASE 82 0.0492
9 GENITAL ABSCESS 19 0.0470
10 CLOSTRIDIUM TEST POSITIVE 100 0.0453
11 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 14 0.0453
12 DISSEMINATED MUCORMYCOSIS 16 0.0406
13 SYSTEMIC CANDIDA 95 0.0378
14 PNEUMOCOCCAL SEPSIS 24 0.0365
15 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 29 0.0353
16 CITROBACTER INFECTION 15 0.0350
17 NEPHRITIS INTERSTITIAL 44 0.0348
18 NECROSIS ISCHAEMIC 16 0.0347
19 RESPIRATORY TRACT INFECTION BACTERIAL 17 0.0341
20 PNEUMATOSIS 15 0.0336
21 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 17 0.0333
22 PERINEAL ABSCESS 15 0.0333
23 ACINETOBACTER INFECTION 35 0.0320
24 FUNGAEMIA 48 0.0305
25 RESPIRATORY TRACT INFECTION FUNGAL 16 0.0303
26 JARISCH-HERXHEIMER REACTION 21 0.0295
27 ENTEROCOCCUS TEST POSITIVE 19 0.0293
28 ABDOMINAL COMPARTMENT SYNDROME 18 0.0283
29 PSEUDOMEMBRANOUS COLITIS 63 0.0282
30 SERRATIA INFECTION 21 0.0282
31 CANDIDA SEPSIS 25 0.0279
32 EOSINOPHILIC PNEUMONIA ACUTE 24 0.0277
33 PSEUDOMONAL BACTERAEMIA 23 0.0269
34 PNEUMONIA NECROTISING 17 0.0263
35 RENAL TUBULAR NECROSIS 251 0.0256
36 ANAEMIA HAEMOLYTIC AUTOIMMUNE 21 0.0254
37 DELAYED GRAFT FUNCTION 17 0.0239
38 TRACHEOBRONCHITIS 18 0.0234
39 MEGACOLON 36 0.0229
40 FUSARIUM INFECTION 16 0.0229
41 RED MAN SYNDROME 20 0.0227
42 PERIRECTAL ABSCESS 24 0.0216
43 MUCORMYCOSIS 56 0.0215
44 DIFFUSE ALVEOLAR DAMAGE 24 0.0209
45 COAGULATION TEST ABNORMAL 16 0.0208
46 DYSBIOSIS 17 0.0207
47 STRONGYLOIDIASIS 33 0.0204
48 LUNG CONSOLIDATION 56 0.0200
49 ENTEROCOCCAL SEPSIS 16 0.0198
50 URINARY TRACT INFECTION ENTEROCOCCAL 18 0.0193
51 BRONCHOPULMONARY ASPERGILLOSIS 149 0.0192
52 PATHOGEN RESISTANCE 174 0.0191
53 CLOSTRIDIUM DIFFICILE COLITIS 200 0.0188
54 NEUTROPENIC INFECTION 18 0.0188
55 CONTINUOUS HAEMODIAFILTRATION 18 0.0184
56 ENTEROCOCCAL INFECTION 88 0.0182
57 TOXIC EPIDERMAL NECROLYSIS 272 0.0179
58 CLOSTRIDIAL INFECTION 60 0.0177
59 APLASTIC ANAEMIA 92 0.0176
60 ASPERGILLUS INFECTION 115 0.0175
61 RASH MORBILLIFORM 48 0.0173
62 ENTEROBACTER INFECTION 29 0.0172
63 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 444 0.0172
64 PULMONARY NOCARDIOSIS 14 0.0170
65 ENTEROCOCCAL BACTERAEMIA 18 0.0170
66 KLEBSIELLA SEPSIS 19 0.0169
67 NEPHROPATHY TOXIC 189 0.0168
68 KLEBSIELLA INFECTION 85 0.0168
69 LARGE INTESTINE INFECTION 20 0.0163
70 CYTOMEGALOVIRUS TEST POSITIVE 29 0.0163
71 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 62 0.0162
72 KOUNIS SYNDROME 36 0.0158
73 PELVIC ABSCESS 18 0.0157
74 STENOTROPHOMONAS INFECTION 21 0.0155
75 HYPERNATRAEMIA 77 0.0154
76 SYSTEMIC MYCOSIS 18 0.0154
77 TUBULOINTERSTITIAL NEPHRITIS 288 0.0154
78 DRUG CLEARANCE DECREASED 20 0.0153
79 PNEUMONIA PSEUDOMONAL 23 0.0150
80 PNEUMONIA FUNGAL 59 0.0149
81 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 48 0.0148
82 ISCHAEMIC CEREBRAL INFARCTION 17 0.0146
83 SEPTIC SHOCK 636 0.0146
84 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 16 0.0145
85 ASPERGILLOSIS 19 0.0145
86 PROCALCITONIN INCREASED 17 0.0145
87 GROIN ABSCESS 17 0.0144
88 PSEUDOMONAS INFECTION 123 0.0143
89 MECHANICAL VENTILATION 27 0.0142
90 DISSEMINATED INTRAVASCULAR COAGULATION 200 0.0142
91 PNEUMONIA STAPHYLOCOCCAL 28 0.0142
92 NECROTISING FASCIITIS 50 0.0142
93 PYURIA 14 0.0141
94 HYPOFIBRINOGENAEMIA 14 0.0141
95 EOSINOPHILIA 247 0.0141
96 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 109 0.0140
97 SPUTUM INCREASED 30 0.0139
98 INFECTIOUS PLEURAL EFFUSION 21 0.0138
99 STREPTOCOCCAL BACTERAEMIA 15 0.0138
100 STAPHYLOCOCCUS TEST POSITIVE 29 0.0137
101 PNEUMOPERITONEUM 25 0.0135
102 MULTIPLE ORGAN DYSFUNCTION SYNDROME 381 0.0134
103 EOSINOPHILIC PNEUMONIA 42 0.0133
104 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 100 0.0133
105 RESUSCITATION 22 0.0133
106 INTESTINAL ISCHAEMIA 73 0.0132
107 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 14 0.0132
108 ACUTE RESPIRATORY DISTRESS SYNDROME 230 0.0130
109 OLIGURIA 79 0.0127
110 RESPIRATORY ACIDOSIS 50 0.0127
111 HEPARIN-INDUCED THROMBOCYTOPENIA 62 0.0126
112 SOFT TISSUE INFECTION 23 0.0126
113 RHONCHI 17 0.0123
114 RASH MACULO-PAPULAR 272 0.0122
115 NEUTROPENIC COLITIS 25 0.0121
116 PNEUMONIA CYTOMEGALOVIRAL 23 0.0118
117 HAEMODYNAMIC INSTABILITY 89 0.0117
118 CRYPTOCOCCOSIS 19 0.0116
119 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 69 0.0116
120 PNEUMOMEDIASTINUM 21 0.0116
121 CHRONIC RESPIRATORY FAILURE 14 0.0116
122 EMPYEMA 23 0.0116
123 LIVEDO RETICULARIS 24 0.0115
124 PNEUMONIA KLEBSIELLA 21 0.0114
125 PSEUDOMONAL SEPSIS 20 0.0114
126 CHEST X-RAY ABNORMAL 35 0.0114
127 METABOLIC ENCEPHALOPATHY 34 0.0113
128 ACUTE RESPIRATORY FAILURE 216 0.0112
129 PYELONEPHRITIS ACUTE 22 0.0112
130 HISTIOCYTOSIS HAEMATOPHAGIC 33 0.0111
131 NECROTISING COLITIS 14 0.0110
132 STAPHYLOCOCCAL BACTERAEMIA 48 0.0110
133 BACTERAEMIA 131 0.0110
134 ISCHAEMIC HEPATITIS 15 0.0109
135 ESCHERICHIA INFECTION 89 0.0108
136 DIABETES INSIPIDUS 26 0.0108
137 LIVER ABSCESS 35 0.0108
138 PNEUMONIA BACTERIAL 98 0.0107
139 INCREASED BRONCHIAL SECRETION 27 0.0105
140 ATELECTASIS 102 0.0105
141 BACTERIAL SEPSIS 34 0.0104
142 LEUKOCYTOSIS 186 0.0103
143 MULTI-ORGAN FAILURE 175 0.0101
144 CLOSTRIDIUM DIFFICILE INFECTION 217 0.0099
145 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 14 0.0099
146 RESPIRATORY ALKALOSIS 16 0.0098
147 VASOPLEGIA SYNDROME 16 0.0098
148 LUNG INFILTRATION 86 0.0097
149 BLOOD CULTURE POSITIVE 29 0.0097
150 AGRANULOCYTOSIS 179 0.0096
151 HYPERCAPNIA 29 0.0096
152 ELECTROCARDIOGRAM T WAVE ABNORMAL 15 0.0096
153 IMMUNE THROMBOCYTOPENIA 44 0.0096
154 PULSELESS ELECTRICAL ACTIVITY 40 0.0096
155 TACHYPNOEA 130 0.0096
156 NOSOCOMIAL INFECTION 21 0.0095
157 VASCULAR DEVICE INFECTION 43 0.0095
158 HEPATITIS FULMINANT 28 0.0094
159 PNEUMONIA LEGIONELLA 15 0.0094
160 AUTOIMMUNE HAEMOLYTIC ANAEMIA 32 0.0093
161 CYTOKINE RELEASE SYNDROME 186 0.0093
162 APLASIA 18 0.0092
163 FEBRILE NEUTROPENIA 609 0.0092
164 MENINGITIS CRYPTOCOCCAL 16 0.0091
165 PULMONARY ALVEOLAR HAEMORRHAGE 51 0.0091
166 CHOLESTASIS 174 0.0091
167 LUNG ABSCESS 19 0.0090
168 BRONCHIAL DISORDER 14 0.0090
169 ACUTE KIDNEY INJURY 1374 0.0090
170 STEVENS-JOHNSON SYNDROME 199 0.0089
171 DEVICE RELATED SEPSIS 18 0.0089
172 HYPERTRANSAMINASAEMIA 62 0.0089
173 NEPHROGENIC ANAEMIA 41 0.0088
174 ENTERITIS INFECTIOUS 15 0.0088
175 CAPILLARY LEAK SYNDROME 18 0.0087
176 MULTIPLE-DRUG RESISTANCE 27 0.0087
177 OTOTOXICITY 16 0.0086
178 CANDIDA INFECTION 146 0.0086
179 RENAL FAILURE ACUTE 365 0.0086
180 RESPIRATORY FAILURE 626 0.0086
181 HYPERPARATHYROIDISM SECONDARY 21 0.0084
182 LUNG OPACITY 22 0.0083
183 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 23 0.0083
184 ADENOVIRUS INFECTION 24 0.0083
185 TRANSPLANT REJECTION 66 0.0082
186 CHOLANGITIS 51 0.0082
187 HYPOXIA 289 0.0082
188 HYPERLACTACIDAEMIA 22 0.0082
189 HEPATITIS CHOLESTATIC 49 0.0081
190 ACIDOSIS 62 0.0081
191 HYPERBILIRUBINAEMIA 84 0.0081
192 NEPHRITIS 27 0.0081
193 CHOLESTATIC LIVER INJURY 18 0.0081
194 TOXIC SKIN ERUPTION 81 0.0080
195 ENDOCARDITIS 41 0.0080
196 PANCYTOPENIA 446 0.0080
197 HAEMODIALYSIS 67 0.0080
198 SEPSIS 889 0.0080
199 LEFT VENTRICULAR HYPERTROPHY 34 0.0079
200 CUTANEOUS VASCULITIS 29 0.0079
201 HUMAN HERPESVIRUS 6 INFECTION 15 0.0079
202 HAEMOTHORAX 23 0.0079
203 CYTOMEGALOVIRUS INFECTION REACTIVATION 35 0.0079
204 ANURIA 68 0.0079
205 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 40 0.0079
206 INFLAMMATORY MARKER INCREASED 39 0.0079
207 ENDOTRACHEAL INTUBATION 22 0.0078
208 HYPERAMMONAEMIA 39 0.0078
209 CYTOMEGALOVIRUS INFECTION 129 0.0078
210 PNEUMATOSIS INTESTINALIS 22 0.0077
211 TOXIC ENCEPHALOPATHY 39 0.0077
212 TYPE IV HYPERSENSITIVITY REACTION 21 0.0077
213 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 25 0.0076
214 CELL DEATH 15 0.0076
215 ENCEPHALOPATHY 185 0.0075
216 DRUG RESISTANCE 193 0.0075
217 ABSCESS LIMB 32 0.0075
218 STAPHYLOCOCCAL SEPSIS 37 0.0075
219 ABDOMINAL INFECTION 19 0.0074
220 THROMBOCYTOSIS 27 0.0074
221 HAEMOLYTIC ANAEMIA 66 0.0074
222 MIXED LIVER INJURY 22 0.0073
223 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 17 0.0073
224 HYPERURICAEMIA 30 0.0073
225 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 16 0.0073
226 ESCHERICHIA BACTERAEMIA 17 0.0072
227 CYTOLYTIC HEPATITIS 24 0.0072
228 HYPOALBUMINAEMIA 56 0.0072
229 LARGE INTESTINE PERFORATION 50 0.0072
230 DERMATITIS EXFOLIATIVE 36 0.0072
231 UROSEPSIS 66 0.0071
232 NEUTROPENIC SEPSIS 51 0.0071
233 DRUG LEVEL INCREASED 117 0.0071
234 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 15 0.0070
235 COAGULOPATHY 117 0.0070
236 DRUG ERUPTION 123 0.0069
237 PNEUMONIA ASPIRATION 173 0.0069
238 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 18 0.0069
239 GASTROINTESTINAL NECROSIS 20 0.0069
240 PERICARDIAL HAEMORRHAGE 15 0.0069
241 CEREBELLAR SYNDROME 15 0.0068
242 HEPATOCELLULAR INJURY 97 0.0068
243 ABDOMINAL ABSCESS 30 0.0068
244 THROMBOCYTOPENIA 753 0.0067
245 INTRA-ABDOMINAL HAEMORRHAGE 16 0.0067
246 PROTHROMBIN TIME PROLONGED 40 0.0067
247 HYPOVOLAEMIC SHOCK 32 0.0067
248 GRAFT VERSUS HOST DISEASE 48 0.0067
249 LONG QT SYNDROME 16 0.0067
250 HEPATIC NECROSIS 25 0.0066
251 COMPLICATIONS OF TRANSPLANTED KIDNEY 15 0.0066
252 TUMOUR LYSIS SYNDROME 58 0.0066
253 FEBRILE BONE MARROW APLASIA 28 0.0066
254 PNEUMOCYSTIS JIROVECII PNEUMONIA 66 0.0066
255 THROMBOTIC MICROANGIOPATHY 64 0.0066
256 DRUG LEVEL ABOVE THERAPEUTIC 30 0.0065
257 CHOLECYSTITIS ACUTE 37 0.0065
258 NEUROTOXICITY 114 0.0065
259 TORSADE DE POINTES 51 0.0065
260 EOSINOPHIL COUNT INCREASED 54 0.0065
261 SHOCK 149 0.0065
262 SERUM FERRITIN INCREASED 34 0.0064
263 BLOOD ALBUMIN DECREASED 51 0.0064
264 VENOOCCLUSIVE DISEASE 16 0.0064
265 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 61 0.0064
266 SHOCK HAEMORRHAGIC 52 0.0064
267 CIRCULATORY COLLAPSE 108 0.0063
268 ELECTROCARDIOGRAM T WAVE INVERSION 14 0.0063
269 RETROPERITONEAL HAEMATOMA 14 0.0063
270 DISEASE COMPLICATION 29 0.0063
271 HEPATIC FUNCTION ABNORMAL 235 0.0063
272 CYTOMEGALOVIRUS VIRAEMIA 28 0.0063
273 ACUTE HEPATIC FAILURE 86 0.0063
274 VENOOCCLUSIVE LIVER DISEASE 31 0.0063
275 ENTEROCOLITIS 36 0.0062
276 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 31 0.0062
277 GLOMERULONEPHRITIS 15 0.0061
278 ANAL ABSCESS 33 0.0061
279 PERIPHERAL ISCHAEMIA 25 0.0061
280 APLASIA PURE RED CELL 21 0.0061
281 SERUM SICKNESS 17 0.0061
282 RESPIRATORY DISTRESS 167 0.0060
283 ACUTE LYMPHOCYTIC LEUKAEMIA 17 0.0060
284 PLEURAL EFFUSION 365 0.0060
285 HYPOKALAEMIA 276 0.0060
286 BLOOD UREA INCREASED 100 0.0060
287 ORTHOPNOEA 19 0.0060
288 MYCOBACTERIUM AVIUM COMPLEX INFECTION 16 0.0060
289 BLOOD CREATININE INCREASED 388 0.0059
290 HEPATIC FAILURE 178 0.0059
291 HEPATOMEGALY 58 0.0059
292 OXYGEN CONSUMPTION INCREASED 14 0.0059
293 ORGANISING PNEUMONIA 29 0.0058
294 BRAIN NATRIURETIC PEPTIDE INCREASED 18 0.0058
295 METABOLIC ACIDOSIS 184 0.0057
296 HAEMOLYSIS 44 0.0057
297 BRAIN HERNIATION 17 0.0057
298 RENAL TUBULAR DISORDER 16 0.0057
299 RETROPERITONEAL HAEMORRHAGE 14 0.0057
300 HYPERVOLAEMIA 28 0.0057
301 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 14 0.0057
302 JAUNDICE CHOLESTATIC 20 0.0057
303 NORMOCHROMIC NORMOCYTIC ANAEMIA 17 0.0057
304 GENERALISED OEDEMA 70 0.0056
305 PETECHIAE 59 0.0056
306 INTRAVENTRICULAR HAEMORRHAGE 14 0.0056
307 FIBRIN D DIMER INCREASED 20 0.0056
308 URINE OUTPUT DECREASED 49 0.0056
309 BONE MARROW FAILURE 113 0.0056
310 BLOOD ALKALINE PHOSPHATASE INCREASED 138 0.0056
311 HYPOPHOSPHATAEMIA 41 0.0055
312 MENTAL STATUS CHANGES 154 0.0055
313 CHOLECYSTITIS 66 0.0055
314 ABSCESS 88 0.0055
315 APPENDICITIS PERFORATED 14 0.0055
316 CLONUS 15 0.0055
317 SUBDURAL HAEMORRHAGE 15 0.0055
318 CARDIAC TAMPONADE 26 0.0055
319 CYSTITIS HAEMORRHAGIC 22 0.0055
320 ISCHAEMIA 25 0.0054
321 FAILURE TO THRIVE 28 0.0054
322 VENTRICULAR TACHYCARDIA 89 0.0054
323 ILEUS PARALYTIC 24 0.0054
324 PNEUMONITIS 146 0.0054
325 ODYNOPHAGIA 32 0.0054
326 ARTHRITIS BACTERIAL 22 0.0054
327 SUSPECTED OFF LABEL USE 24 0.0053
328 ASCITES 156 0.0053
329 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 14 0.0053
330 DRUG-INDUCED LIVER INJURY 165 0.0053
331 CEREBRAL ISCHAEMIA 27 0.0052
332 PULMONARY HAEMORRHAGE 41 0.0052
333 PNEUMOTHORAX 83 0.0052
334 SINUS TACHYCARDIA 74 0.0052
335 SKIN NECROSIS 27 0.0052
336 STAPHYLOCOCCAL INFECTION 171 0.0052
337 ESCHERICHIA SEPSIS 15 0.0052
338 RALES 30 0.0052
339 HEPATOTOXICITY 115 0.0052
340 STATUS EPILEPTICUS 58 0.0051
341 STRIDOR 15 0.0051
342 HYDRONEPHROSIS 38 0.0051
343 HAEMORRHAGIC DIATHESIS 18 0.0051
344 RENAL IMPAIRMENT 424 0.0050
345 PULSE ABSENT 24 0.0050
346 DECUBITUS ULCER 41 0.0050
347 NECROSIS 28 0.0050
348 ACUTE GRAFT VERSUS HOST DISEASE 23 0.0050
349 HEPATIC CYST 17 0.0050
350 KIDNEY TRANSPLANT REJECTION 24 0.0050
351 INTERSTITIAL LUNG DISEASE 242 0.0050
352 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 27 0.0050
353 ESCHERICHIA URINARY TRACT INFECTION 21 0.0049
354 BLOOD BILIRUBIN INCREASED 132 0.0049
355 DEMYELINATION 20 0.0049
356 CARDIOGENIC SHOCK 70 0.0049
357 ASPARTATE AMINOTRANSFERASE INCREASED 259 0.0049
358 GAMMA-GLUTAMYLTRANSFERASE INCREASED 108 0.0049
359 PURPURA 43 0.0049
360 MALNUTRITION 54 0.0048
361 SUBCUTANEOUS ABSCESS 23 0.0048
362 MUCOSAL INFLAMMATION 124 0.0047
363 BILE DUCT STONE 15 0.0047
364 DELIRIUM 163 0.0047
365 ALANINE AMINOTRANSFERASE INCREASED 288 0.0047
366 WOUND COMPLICATION 16 0.0047
367 LEUKOPENIA 232 0.0046
368 LOSS OF EMPLOYMENT 14 0.0046
369 ABDOMINAL TENDERNESS 23 0.0046
370 ACUTE MYELOID LEUKAEMIA 72 0.0046
371 PYELONEPHRITIS 40 0.0046
372 HYPERTHERMIA 35 0.0046
373 BRAIN DEATH 14 0.0045
374 OESOPHAGEAL CANDIDIASIS 18 0.0045
375 ILEUS 56 0.0045
376 CARDIAC FAILURE ACUTE 30 0.0045
377 ENDOPHTHALMITIS 27 0.0045
378 LEFT VENTRICULAR DYSFUNCTION 30 0.0045
379 ELECTROLYTE IMBALANCE 52 0.0045
380 ORGAN FAILURE 18 0.0045
381 END STAGE RENAL DISEASE 81 0.0044
382 CELLULITIS 223 0.0044
383 RENAL FAILURE CHRONIC 34 0.0044
384 RENAL FAILURE 585 0.0044
385 HEPATIC LESION 19 0.0044
386 CARDIOMEGALY 54 0.0044
387 DIALYSIS 62 0.0044
388 RHINOVIRUS INFECTION 17 0.0044
389 BLOOD LACTIC ACID INCREASED 23 0.0044
390 SPLENOMEGALY 51 0.0043
391 DEVICE RELATED INFECTION 67 0.0043
392 WOUND SECRETION 17 0.0043
393 HAEMOPTYSIS 121 0.0043
394 METABOLIC DISORDER 25 0.0043
395 BLOOD CREATINE INCREASED 19 0.0043
396 MULTIPLE MYELOMA 20 0.0043
397 ACUTE PULMONARY OEDEMA 24 0.0043
398 HYPOVOLAEMIA 25 0.0043
399 PYREXIA 1474 0.0043
400 AZOTAEMIA 17 0.0043
401 CANDIDIASIS 17 0.0042
402 VENTRICULAR FIBRILLATION 47 0.0042
403 ECCHYMOSIS 29 0.0042
404 UPPER GASTROINTESTINAL HAEMORRHAGE 71 0.0042
405 INTERNATIONAL NORMALISED RATIO INCREASED 120 0.0042
406 ERYTHEMA MULTIFORME 39 0.0042
407 LYMPHOPENIA 59 0.0042
408 HYPERKALAEMIA 146 0.0042
409 OCULAR ICTERUS 18 0.0041
410 ATRIOVENTRICULAR BLOCK FIRST DEGREE 18 0.0041
411 RASH VESICULAR 20 0.0041
412 ATRIAL FLUTTER 33 0.0041
413 STREPTOCOCCAL INFECTION 23 0.0041
414 NEUTROPENIA 561 0.0041
415 JAUNDICE 111 0.0041
416 RASH PUSTULAR 30 0.0041
417 BLOOD LACTATE DEHYDROGENASE INCREASED 65 0.0041
418 LEUKOENCEPHALOPATHY 15 0.0040
419 MYOCLONUS 48 0.0040
420 INTESTINAL PERFORATION 45 0.0040
421 CREATININE RENAL CLEARANCE DECREASED 16 0.0040
422 RIGHT VENTRICULAR FAILURE 28 0.0040
423 ARTERIOSPASM CORONARY 16 0.0040
424 CARDIAC ARREST 328 0.0040
425 NEONATAL RESPIRATORY DISTRESS SYNDROME 14 0.0040
426 HEPATITIS 101 0.0039
427 GUILLAIN-BARRE SYNDROME 19 0.0039
428 BACTERIAL INFECTION 73 0.0039
429 PULMONARY FUNCTION TEST DECREASED 17 0.0039
430 DERMATITIS BULLOUS 28 0.0039
431 RHABDOMYOLYSIS 161 0.0039
432 HEPATIC ENCEPHALOPATHY 36 0.0039
433 BK VIRUS INFECTION 13 0.0039
434 NEUTROPHIL COUNT DECREASED 157 0.0038
435 C-REACTIVE PROTEIN INCREASED 140 0.0038
436 UNRESPONSIVE TO STIMULI 99 0.0038
437 TRANSAMINASES INCREASED 85 0.0038
438 MELAENA 84 0.0038
439 OSTEOMYELITIS 69 0.0038
440 HAEMATOCRIT DECREASED 75 0.0038
441 WHITE BLOOD CELL COUNT INCREASED 145 0.0038
442 FLUID OVERLOAD 55 0.0038
443 HYPERPYREXIA 16 0.0038
444 TRICUSPID VALVE INCOMPETENCE 30 0.0038
445 SEROTONIN SYNDROME 72 0.0037
446 SMALL INTESTINAL OBSTRUCTION 46 0.0037
447 LYMPHOCYTE COUNT DECREASED 66 0.0037
448 COVID-19 PNEUMONIA 44 0.0037
449 PERICARDIAL EFFUSION 86 0.0037
450 NEUTROPHIL COUNT INCREASED 38 0.0037
451 HERPES SIMPLEX 24 0.0037
452 DUODENAL ULCER 26 0.0037
453 HYPOTENSION 739 0.0037
454 HYPOTHERMIA 37 0.0037
455 GANGRENE 22 0.0036
456 BREATH SOUNDS ABNORMAL 18 0.0036
457 EXTRAVASATION 15 0.0036
458 ADRENAL INSUFFICIENCY 44 0.0036
459 DRUG INTERACTION 573 0.0036
460 SPINAL CORD COMPRESSION 14 0.0036
461 ERYSIPELAS 18 0.0036
462 LACTIC ACIDOSIS 116 0.0036
463 SCOLIOSIS 22 0.0035
464 ANAPHYLACTIC REACTION 196 0.0035
465 PLATELET COUNT DECREASED 378 0.0035
466 SUBARACHNOID HAEMORRHAGE 36 0.0035
467 ELECTROCARDIOGRAM QT PROLONGED 127 0.0035
468 HYPOMAGNESAEMIA 49 0.0035
469 IMMUNOSUPPRESSION 31 0.0035
470 CEREBRAL ATROPHY 14 0.0035
471 CACHEXIA 18 0.0035
472 BRAIN INJURY 35 0.0035
473 HAEMORRHAGE INTRACRANIAL 52 0.0035
474 ENCEPHALITIS 24 0.0035
475 ARTHRITIS INFECTIVE 16 0.0034
476 MITRAL VALVE INCOMPETENCE 39 0.0034
477 ATRIOVENTRICULAR BLOCK COMPLETE 23 0.0034
478 DIVERTICULUM INTESTINAL 15 0.0034
479 NEPHROPATHY 32 0.0034
480 TROPONIN INCREASED 26 0.0034
481 ALTERED STATE OF CONSCIOUSNESS 74 0.0034
482 BRONCHIECTASIS 23 0.0034
483 PULMONARY TOXICITY 24 0.0034
484 DIVERTICULUM 24 0.0034
485 EMBOLISM 28 0.0034
486 RED CELL DISTRIBUTION WIDTH INCREASED 14 0.0034
487 GASTROINTESTINAL PERFORATION 14 0.0034
488 TACHYCARDIA 299 0.0034
489 PATHOLOGICAL FRACTURE 17 0.0033
490 PULMONARY OEDEMA 150 0.0033
491 SUPRAVENTRICULAR TACHYCARDIA 32 0.0033
492 COLITIS 126 0.0033
493 HAEMATURIA 113 0.0033
494 HEPATIC CYTOLYSIS 42 0.0033
495 PURULENT DISCHARGE 14 0.0033
496 RESPIRATORY RATE INCREASED 29 0.0033
497 ORAL CANDIDIASIS 43 0.0033
498 DRUG LEVEL BELOW THERAPEUTIC 18 0.0033
499 CYSTIC FIBROSIS 18 0.0032
500 BRAIN OEDEMA 41 0.0032
501 TRANSFUSION 34 0.0032
502 HEPATITIS ACUTE 21 0.0032
503 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 177 0.0032
504 SINUS BRADYCARDIA 31 0.0032
505 PNEUMONIA 1016 0.0031
506 LIVER INJURY 77 0.0031
507 CARDIO-RESPIRATORY ARREST 130 0.0031
508 LIVER FUNCTION TEST ABNORMAL 90 0.0031
509 FLANK PAIN 29 0.0031
510 ARTERIOSCLEROSIS 29 0.0031
511 DRUG LEVEL DECREASED 31 0.0030
512 CARDIOTOXICITY 27 0.0030
513 ANAPHYLACTIC SHOCK 78 0.0030
514 RENAL CYST 24 0.0030
515 HYPOCALCAEMIA 57 0.0030
516 CHOLECYSTITIS CHRONIC 20 0.0030
517 TENDERNESS 31 0.0030
518 CARDIAC VALVE DISEASE 17 0.0030
519 COLITIS ISCHAEMIC 20 0.0030
520 PROCTALGIA 19 0.0030
521 DYSLIPIDAEMIA 15 0.0030
522 CYTOPENIA 36 0.0029
523 SKIN WARM 17 0.0029
524 VASCULITIS 34 0.0029
525 PERITONITIS 60 0.0029
526 LUNG INFECTION 45 0.0029
527 RENAL INJURY 86 0.0029
528 MYOPATHY 25 0.0029
529 HYPOGAMMAGLOBULINAEMIA 19 0.0029
530 MOUTH HAEMORRHAGE 21 0.0029
531 BLOOD CALCIUM DECREASED 32 0.0028
532 BODY TEMPERATURE INCREASED 58 0.0028
533 LIVER FUNCTION TEST INCREASED 61 0.0028
534 PAPULE 20 0.0028
535 HYPERCALCAEMIA 35 0.0028
536 ANAEMIA 537 0.0028
537 DEPRESSED LEVEL OF CONSCIOUSNESS 111 0.0028
538 ELECTROCARDIOGRAM ABNORMAL 22 0.0028
539 APPENDICITIS 26 0.0028
540 DYSPHORIA 14 0.0028
541 RASH ERYTHEMATOUS 132 0.0028
542 JOINT EFFUSION 19 0.0028
543 SPUTUM DISCOLOURED 26 0.0027
544 ASPIRATION 30 0.0027
545 HEPATIC STEATOSIS 51 0.0027
546 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 14 0.0027
547 LIVER DISORDER 121 0.0027
548 EPSTEIN-BARR VIRUS INFECTION 17 0.0027
549 PERIPHERAL VASCULAR DISORDER 14 0.0027
550 ARTERIOSCLEROSIS CORONARY ARTERY 18 0.0027
551 PANCREATITIS ACUTE 61 0.0027
552 LOWER GASTROINTESTINAL HAEMORRHAGE 20 0.0027
553 NEUROLEPTIC MALIGNANT SYNDROME 32 0.0027
554 MYELODYSPLASTIC SYNDROME 39 0.0027
555 PLEURISY 16 0.0027
556 MYELOSUPPRESSION 97 0.0027
557 CARDIAC FAILURE 215 0.0027
558 BRADYCARDIA 142 0.0027
559 POSTOPERATIVE WOUND INFECTION 18 0.0027
560 ENTERITIS 17 0.0027
561 GASTROINTESTINAL HAEMORRHAGE 222 0.0027
562 SUBDURAL HAEMATOMA 38 0.0027
563 OXYGEN SATURATION DECREASED 149 0.0026
564 PULMONARY HYPERTENSION 55 0.0026
565 NEUTROPHILIA 15 0.0026
566 HYPERGLYCAEMIA 96 0.0026
567 RASH GENERALISED 68 0.0026
568 HAEMOGLOBIN DECREASED 269 0.0026
569 ACUTE MYOCARDIAL INFARCTION 77 0.0026
570 WHITE BLOOD CELL COUNT DECREASED 282 0.0026
571 HYPERLIPIDAEMIA 31 0.0026
572 PULMONARY CONGESTION 34 0.0026
573 ATRIAL FIBRILLATION 250 0.0026
574 HEPATIC ENZYME INCREASED 173 0.0025
575 GLOMERULAR FILTRATION RATE DECREASED 31 0.0025
576 OBSTRUCTIVE AIRWAYS DISORDER 28 0.0025
577 OCCUPATIONAL EXPOSURE TO PRODUCT 16 0.0025
578 GENERALISED ERYTHEMA 14 0.0025
579 GRANULOCYTOPENIA 14 0.0025
580 LYMPHADENOPATHY 87 0.0025
581 ORAL DISORDER 18 0.0025
582 HYPONATRAEMIA 138 0.0024
583 AUTOIMMUNE HEPATITIS 17 0.0024
584 VENTRICULAR EXTRASYSTOLES 25 0.0024
585 HYPERTRIGLYCERIDAEMIA 14 0.0024
586 DERMATITIS ALLERGIC 30 0.0024
587 MULTIPLE INJURIES 15 0.0024
588 CEREBRAL HAEMORRHAGE 85 0.0024
589 GENERALISED TONIC-CLONIC SEIZURE 39 0.0024
590 BRONCHOSPASM 33 0.0023
591 CYANOSIS 36 0.0023
592 OEDEMA 124 0.0023
593 SECOND PRIMARY MALIGNANCY 19 0.0023
594 CHILLS 267 0.0023
595 HYPOGLYCAEMIA 110 0.0023
596 MOTOR DYSFUNCTION 23 0.0023
597 CARDIOMYOPATHY 33 0.0022
598 FUNGAL INFECTION 74 0.0022
599 RESPIRATORY ARREST 61 0.0022
600 FACE OEDEMA 37 0.0022
601 BLOOD POTASSIUM INCREASED 35 0.0022
602 INJURY 151 0.0021
603 POST PROCEDURAL HAEMORRHAGE 25 0.0021
604 REFUSAL OF TREATMENT BY PATIENT 14 0.0021
605 RESPIRATORY DISORDER 64 0.0021
606 MYOSITIS 19 0.0021
607 ECONOMIC PROBLEM 32 0.0021
608 WOUND INFECTION 23 0.0021
609 ANHEDONIA 55 0.0021
610 CORONARY ARTERY DISEASE 63 0.0021
611 DIFFUSE LARGE B-CELL LYMPHOMA 16 0.0021
612 POLYURIA 17 0.0021
613 GASTROENTERITIS 30 0.0021
614 MUSCLE RIGIDITY 24 0.0020
615 CEREBRAL INFARCTION 49 0.0020
616 GENERAL PHYSICAL HEALTH DETERIORATION 231 0.0020
617 RESPIRATORY TRACT INFECTION 52 0.0020
618 DIVERTICULITIS 55 0.0020
619 CONDITION AGGRAVATED 603 0.0020
620 SKIN LESION 54 0.0020
621 SKIN INFECTION 22 0.0020
622 HYPOPHAGIA 50 0.0020
623 DEEP VEIN THROMBOSIS 127 0.0020
624 PULMONARY MASS 29 0.0019
625 BLISTER 109 0.0019
626 LUNG DISORDER 95 0.0019
627 ATAXIA 23 0.0019
628 SPINAL OSTEOARTHRITIS 17 0.0019
629 ACUTE CORONARY SYNDROME 16 0.0019
630 OESOPHAGITIS 21 0.0019
631 CHRONIC KIDNEY DISEASE 146 0.0019
632 CONFUSIONAL STATE 309 0.0019
633 BLOOD CREATINE PHOSPHOKINASE INCREASED 55 0.0019
634 PULMONARY EMBOLISM 181 0.0019
635 HYPOTONIA 19 0.0019
636 PROTEINURIA 36 0.0019
637 HAEMATOMA 49 0.0019
638 THERAPY NON-RESPONDER 85 0.0019
639 CHOLELITHIASIS 62 0.0019
640 NO THERAPEUTIC RESPONSE 23 0.0019
641 INFECTION 271 0.0019
642 BLOOD DISORDER 15 0.0019
643 EJECTION FRACTION DECREASED 29 0.0019
644 CARDIAC FAILURE CONGESTIVE 147 0.0018
645 PREMATURE DELIVERY 29 0.0018
646 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 16 0.0018
647 LACERATION 17 0.0018
648 MOUTH ULCERATION 38 0.0018
649 HYPOKINESIA 26 0.0018
650 PERICARDITIS 30 0.0018
651 FISTULA 20 0.0018
652 ANAL INCONTINENCE 16 0.0018
653 PULMONARY FIBROSIS 34 0.0018
654 CHROMATURIA 40 0.0018
655 UVEITIS 24 0.0018
656 EPILEPSY 54 0.0018
657 URINARY TRACT INFECTION 300 0.0018
658 COMA 83 0.0017
659 OEDEMA PERIPHERAL 211 0.0017
660 TREATMENT FAILURE 142 0.0017
661 RED BLOOD CELL COUNT DECREASED 49 0.0017
662 INCONTINENCE 18 0.0017
663 PRODUCT USE IN UNAPPROVED INDICATION 421 0.0017
664 BLOOD SODIUM DECREASED 32 0.0017
665 DYSPHAGIA 160 0.0017
666 EMPHYSEMA 17 0.0017
667 ABDOMINAL PAIN 390 0.0017
668 APNOEA 13 0.0017
669 HEMIPARESIS 28 0.0017
670 HEPATIC CIRRHOSIS 31 0.0016
671 BLOOD PRESSURE DECREASED 109 0.0016
672 SKIN REACTION 23 0.0016
673 INFUSION RELATED REACTION 108 0.0016
674 IRON DEFICIENCY ANAEMIA 15 0.0016
675 CARDIAC MURMUR 14 0.0016
676 POST PROCEDURAL COMPLICATION 31 0.0016
677 RESPIRATORY SYNCYTIAL VIRUS INFECTION 14 0.0016
678 DIARRHOEA HAEMORRHAGIC 15 0.0016
679 FEAR 43 0.0016
680 PRODUCTIVE COUGH 76 0.0016
681 RECTAL HAEMORRHAGE 68 0.0016
682 HAEMATEMESIS 40 0.0016
683 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 82 0.0016
684 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 16 0.0016
685 APHASIA 47 0.0016
686 RENAL DISORDER 72 0.0015
687 HIATUS HERNIA 20 0.0015
688 DRUG TOXICITY 21 0.0015
689 RASH PRURITIC 83 0.0015
690 LETHARGY 88 0.0015
691 DERMATITIS 32 0.0015
692 SECRETION DISCHARGE 19 0.0015
693 RASH 661 0.0015
694 INTERVERTEBRAL DISC DEGENERATION 14 0.0015
695 POLYNEUROPATHY 18 0.0015
696 STOMATITIS 91 0.0015
697 MUSCLE ATROPHY 19 0.0015
698 DISEASE PROGRESSION 177 0.0015
699 MYOCARDIAL ISCHAEMIA 17 0.0015
700 UPPER RESPIRATORY TRACT INFECTION 69 0.0015
701 LYMPHOMA 23 0.0015
702 ORAL HERPES 29 0.0015
703 SKIN ULCER 38 0.0015
704 GALLBLADDER DISORDER 26 0.0015
705 DISORIENTATION 57 0.0014
706 AGITATION 103 0.0014
707 ANGIOEDEMA 62 0.0014
708 METASTASES TO BONE 23 0.0014
709 OFF LABEL USE 1227 0.0014
710 ISCHAEMIC STROKE 25 0.0014
711 ABDOMINAL PAIN LOWER 35 0.0014
712 FAECES DISCOLOURED 30 0.0014
713 OBESITY 22 0.0014
714 PULMONARY ARTERIAL HYPERTENSION 20 0.0014
715 SKIN LACERATION 15 0.0014
716 INJECTION SITE EXTRAVASATION 17 0.0014
717 WHEEZING 81 0.0014
718 CONVULSION 78 0.0014
719 BLOOD POTASSIUM DECREASED 41 0.0014
720 DEHYDRATION 181 0.0014
721 ARRHYTHMIA 64 0.0014
722 INTRAOCULAR PRESSURE INCREASED 17 0.0013
723 GASTRITIS 35 0.0013
724 DYSPNOEA EXERTIONAL 50 0.0013
725 DYSPNOEA 745 0.0013
726 DRUG INEFFECTIVE 1731 0.0013
727 RESTLESSNESS 48 0.0013
728 DYSARTHRIA 49 0.0013
729 BEDRIDDEN 17 0.0013
730 TOXICITY TO VARIOUS AGENTS 218 0.0013
731 URINARY RETENTION 43 0.0013
732 HAEMORRHOIDS 25 0.0013
733 INTERVERTEBRAL DISC PROTRUSION 28 0.0013
734 HALLUCINATION, VISUAL 27 0.0013
735 IMMUNODEFICIENCY 19 0.0013
736 DIARRHOEA 813 0.0013
737 OSTEOPENIA 19 0.0013
738 DYSURIA 46 0.0012
739 INFLAMMATION 64 0.0012
740 CONJUNCTIVITIS 23 0.0012
741 HYPERTENSION 260 0.0012
742 PLATELET COUNT INCREASED 16 0.0012
743 RESPIRATORY DEPRESSION 15 0.0012
744 MYOCARDITIS 14 0.0012
745 PHARYNGITIS 15 0.0012
746 ABDOMINAL DISTENSION 125 0.0012
747 HYPOAESTHESIA ORAL 18 0.0012
748 DEAFNESS 31 0.0012
749 NERVOUS SYSTEM DISORDER 37 0.0012
750 BRONCHITIS 87 0.0012
751 PANCREATITIS 62 0.0012
752 MYDRIASIS 15 0.0012
753 MATERNAL EXPOSURE DURING PREGNANCY 104 0.0012
754 HAEMATOCHEZIA 64 0.0012
755 BURSITIS 14 0.0012
756 NODULE 15 0.0011
757 ORTHOSTATIC HYPOTENSION 20 0.0011
758 HALLUCINATION 86 0.0011
759 OSTEONECROSIS OF JAW 28 0.0011
760 SEIZURE 129 0.0011
761 ANGINA PECTORIS 32 0.0011
762 MALIGNANT NEOPLASM PROGRESSION 114 0.0011
763 HAEMORRHAGE 116 0.0011
764 GASTRIC ULCER 21 0.0011
765 ERYTHEMA 226 0.0011
766 PREMATURE BABY 33 0.0011
767 EPISTAXIS 82 0.0011
768 ANOREXIA 14 0.0011
769 VOMITING 508 0.0011
770 EAR PAIN 21 0.0011
771 LOWER RESPIRATORY TRACT INFECTION 49 0.0011
772 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
773 ORAL PAIN 24 0.0011
774 PALLOR 29 0.0011
775 PAIN IN JAW 30 0.0011
776 SCAR 18 0.0011
777 COUGH 294 0.0010
778 MUSCLE TWITCHING 24 0.0010
779 OSTEOARTHRITIS 44 0.0010
780 MUSCULOSKELETAL CHEST PAIN 16 0.0010
781 LOCALISED INFECTION 25 0.0010
782 COVID-19 181 0.0010
783 SYNCOPE 102 0.0010
784 LABORATORY TEST ABNORMAL 30 0.0010
785 DECREASED APPETITE 235 0.0010
786 SINUS DISORDER 20 0.0010
787 COORDINATION ABNORMAL 14 0.0010
788 HYPOTHYROIDISM 32 0.0010
789 HYPERSENSITIVITY 184 0.0010
790 TYPE 2 DIABETES MELLITUS 33 0.0010
791 UNEVALUABLE EVENT 74 0.0010
792 PHARYNGEAL OEDEMA 15 0.0010
793 BLOOD PRESSURE SYSTOLIC INCREASED 19 0.0010
794 CHEST DISCOMFORT 99 0.0010
795 COMPLICATION ASSOCIATED WITH DEVICE 14 0.0010
796 THERAPY PARTIAL RESPONDER 15 0.0010
797 CHEST PAIN 176 0.0009
798 NEOPLASM PROGRESSION 33 0.0009
799 SKIN EXFOLIATION 80 0.0009
800 BLOOD URINE PRESENT 18 0.0009
801 TOOTHACHE 17 0.0009
802 RETCHING 20 0.0009
803 NEPHROLITHIASIS 43 0.0009
804 VISUAL ACUITY REDUCED 31 0.0009
805 BONE DISORDER 17 0.0009
806 VIRAL INFECTION 31 0.0009
807 HERPES ZOSTER 53 0.0009
808 RASH MACULAR 32 0.0009
809 PRESYNCOPE 22 0.0009
810 TENDONITIS 14 0.0009
811 PROCEDURAL PAIN 25 0.0009
812 LIP SWELLING 30 0.0009
813 EMOTIONAL DISTRESS 109 0.0009
814 SKIN DISORDER 30 0.0009
815 MUSCULAR WEAKNESS 102 0.0009
816 CONTRAINDICATED PRODUCT ADMINISTERED 27 0.0009
817 SWELLING FACE 58 0.0009
818 NEUROPATHY PERIPHERAL 84 0.0009
819 CYSTITIS 28 0.0009
820 INTESTINAL OBSTRUCTION 33 0.0009
821 RIB FRACTURE 18 0.0009
822 KIDNEY INFECTION 17 0.0009
823 LOCAL SWELLING 15 0.0009
824 ASTHENIA 323 0.0009
825 IMPAIRED HEALING 28 0.0009
826 MENTAL DISORDER 37 0.0008
827 HYPERHIDROSIS 109 0.0008
828 INCREASED APPETITE 16 0.0008
829 SWOLLEN TONGUE 26 0.0008
830 HEART RATE INCREASED 82 0.0008
831 NEURALGIA 20 0.0008
832 DISEASE RECURRENCE 39 0.0008
833 PRODUCT USE ISSUE 153 0.0008
834 PRURITUS 309 0.0008
835 URTICARIA 134 0.0008
836 HEART RATE IRREGULAR 18 0.0008
837 GASTROINTESTINAL DISORDER 70 0.0008
838 GOUT 14 0.0008
839 TREMOR 129 0.0008
840 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 18 0.0008
841 TREATMENT NONCOMPLIANCE 42 0.0008
842 OROPHARYNGEAL PAIN 71 0.0008
843 CONSTIPATION 167 0.0008
844 LOSS OF CONSCIOUSNESS 98 0.0008
845 OSTEONECROSIS 25 0.0008
846 MEDICATION ERROR 42 0.0008
847 BLOOD PRESSURE ABNORMAL 15 0.0008
848 THROMBOSIS 60 0.0007
849 URINARY INCONTINENCE 22 0.0007
850 EXPOSURE DURING PREGNANCY 46 0.0007
851 PRURITUS GENERALISED 16 0.0007
852 BACK PAIN 171 0.0007
853 PRODUCT PRESCRIBING ISSUE 16 0.0007
854 DYSTONIA 14 0.0007
855 PLASMA CELL MYELOMA 28 0.0007
856 OSTEOPOROSIS 29 0.0007
857 NAUSEA 549 0.0007
858 GASTROOESOPHAGEAL REFLUX DISEASE 55 0.0007
859 FEELING COLD 19 0.0007
860 NECK PAIN 38 0.0007
861 FLUID RETENTION 34 0.0007
862 MALAISE 292 0.0007
863 WEIGHT DECREASED 185 0.0007
864 JOINT INJURY 14 0.0007
865 PAIN 402 0.0007
866 INTENTIONAL PRODUCT USE ISSUE 57 0.0007
867 ANXIETY 185 0.0006
868 ECZEMA 34 0.0006
869 SPEECH DISORDER 34 0.0006
870 WOUND 18 0.0006
871 DIABETES MELLITUS 49 0.0006
872 DRUG INTOLERANCE 61 0.0006
873 SKIN DISCOLOURATION 29 0.0006
874 NASAL CONGESTION 37 0.0006
875 ACCIDENTAL OVERDOSE 23 0.0006
876 RASH PAPULAR 14 0.0006
877 MOVEMENT DISORDER 20 0.0006
878 NIGHT SWEATS 20 0.0006
879 RHINORRHOEA 40 0.0006
880 INFLUENZA 69 0.0006
881 SEDATION 16 0.0006
882 SOMNOLENCE 121 0.0006
883 DYSPHONIA 35 0.0006
884 EYE PAIN 33 0.0006
885 DIABETIC KETOACIDOSIS 14 0.0006
886 COGNITIVE DISORDER 27 0.0006
887 FOETAL EXPOSURE DURING PREGNANCY 47 0.0006
888 DIPLOPIA 15 0.0006
889 SWELLING 54 0.0006
890 FALL 188 0.0006
891 EXTRAPYRAMIDAL DISORDER 14 0.0006
892 TRANSIENT ISCHAEMIC ATTACK 19 0.0006
893 FLUSHING 57 0.0006
894 PALPITATIONS 65 0.0006
895 MUSCULOSKELETAL PAIN 29 0.0006
896 POLLAKIURIA 23 0.0006
897 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
898 HEAD INJURY 17 0.0005
899 SINUSITIS 54 0.0005
900 ABDOMINAL PAIN UPPER 107 0.0005
901 FEMUR FRACTURE 16 0.0005
902 LIMB INJURY 14 0.0005
903 PARAESTHESIA 81 0.0005
904 HEART RATE DECREASED 18 0.0005
905 DEPRESSION 116 0.0005
906 CONTUSION 49 0.0005
907 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 36 0.0005
908 DYSKINESIA 20 0.0005
909 DRUG ADMINISTRATION ERROR 15 0.0005
910 PERIPHERAL SWELLING 75 0.0005
911 CEREBROVASCULAR ACCIDENT 82 0.0005
912 BLOOD PRESSURE INCREASED 74 0.0005
913 SYSTEMIC LUPUS ERYTHEMATOSUS 17 0.0005
914 DYSPEPSIA 47 0.0005
915 PSYCHOTIC DISORDER 14 0.0005
916 MYOCARDIAL INFARCTION 81 0.0005
917 VAGINAL HAEMORRHAGE 20 0.0005
918 GAIT DISTURBANCE 88 0.0005
919 DEATH 396 0.0005
920 DISCOMFORT 28 0.0005
921 EYE SWELLING 17 0.0005
922 THERAPEUTIC RESPONSE DECREASED 27 0.0004
923 VISUAL IMPAIRMENT 55 0.0004
924 AGGRESSION 22 0.0004
925 HYPOAESTHESIA 65 0.0004
926 ILL-DEFINED DISORDER 26 0.0004
927 PAIN IN EXTREMITY 126 0.0004
928 FATIGUE 331 0.0004
929 FLATULENCE 24 0.0004
930 OVERDOSE 91 0.0004
931 MYALGIA 70 0.0004
932 PANIC ATTACK 15 0.0004
933 ABDOMINAL DISCOMFORT 68 0.0004
934 BALANCE DISORDER 35 0.0004
935 MOBILITY DECREASED 29 0.0004
936 COLITIS ULCERATIVE 18 0.0004
937 WEIGHT INCREASED 88 0.0004
938 BONE PAIN 23 0.0004
939 ARTHRALGIA 163 0.0004
940 THERAPY CESSATION 20 0.0004
941 MUSCULOSKELETAL STIFFNESS 34 0.0004
942 ASTHMA 43 0.0004
943 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
944 JOINT SWELLING 44 0.0004
945 FEELING HOT 22 0.0004
946 BLOOD GLUCOSE INCREASED 67 0.0004
947 DIZZINESS 175 0.0004
948 ABORTION SPONTANEOUS 14 0.0003
949 HYPOACUSIS 15 0.0003
950 INTENTIONAL PRODUCT MISUSE 30 0.0003
951 BURNING SENSATION 24 0.0003
952 LUNG NEOPLASM MALIGNANT 14 0.0003
953 INFLUENZA LIKE ILLNESS 28 0.0003
954 HEADACHE 208 0.0003
955 VERTIGO 20 0.0003
956 ARTHROPATHY 18 0.0003
957 DRUG WITHDRAWAL SYNDROME 28 0.0003
958 OCULAR HYPERAEMIA 15 0.0003
959 MUSCLE SPASMS 58 0.0003
960 DISTURBANCE IN ATTENTION 17 0.0003
961 THROAT IRRITATION 14 0.0003
962 INTENTIONAL OVERDOSE 20 0.0003
963 ILLNESS 32 0.0003
964 INSOMNIA 81 0.0003
965 DRY MOUTH 24 0.0003
966 MULTIPLE SCLEROSIS 14 0.0003
967 NO ADVERSE EVENT 51 0.0003
968 ADVERSE DRUG REACTION 25 0.0003
969 CARDIAC DISORDER 26 0.0003
970 VISION BLURRED 37 0.0003
971 DEPRESSED MOOD 14 0.0003
972 RHEUMATOID ARTHRITIS 30 0.0003
973 CATARACT 15 0.0003
974 AMNESIA 16 0.0002
975 ARTHRITIS 19 0.0002
976 HOSPITALISATION 37 0.0002
977 ALOPECIA 45 0.0002
978 SKIN BURNING SENSATION 16 0.0002
979 DYSGEUSIA 15 0.0002
980 INCORRECT DOSE ADMINISTERED 46 0.0002
981 MIGRAINE 19 0.0002
982 HOT FLUSH 15 0.0002
983 MEMORY IMPAIRMENT 27 0.0002
984 NASOPHARYNGITIS 36 0.0002
985 FEELING ABNORMAL 40 0.0002
986 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 30 0.0002
987 DRY SKIN 21 0.0002
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 29 0.0001
989 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
990 PRODUCT QUALITY ISSUE 17 0.0001
991 PSORIASIS 15 0.0001
992 INJECTION SITE ERYTHEMA 14 0.0001
993 DRUG DEPENDENCE 15 0.0001
994 PRODUCT DOSE OMISSION ISSUE 27 0.0001
995 INJECTION SITE PAIN 21 0.0001